Corremans, R.; Vervaet, B.A.; Dams, G.; D’Haese, P.C.; Verhulst, A.
Metformin and Canagliflozin Are Equally Renoprotective in Diabetic Kidney Disease but Have No Synergistic Effect. Int. J. Mol. Sci. 2023, 24, 9043.
https://doi.org/10.3390/ijms24109043
AMA Style
Corremans R, Vervaet BA, Dams G, D’Haese PC, Verhulst A.
Metformin and Canagliflozin Are Equally Renoprotective in Diabetic Kidney Disease but Have No Synergistic Effect. International Journal of Molecular Sciences. 2023; 24(10):9043.
https://doi.org/10.3390/ijms24109043
Chicago/Turabian Style
Corremans, Raphaëlle, Benjamin A. Vervaet, Geert Dams, Patrick C. D’Haese, and Anja Verhulst.
2023. "Metformin and Canagliflozin Are Equally Renoprotective in Diabetic Kidney Disease but Have No Synergistic Effect" International Journal of Molecular Sciences 24, no. 10: 9043.
https://doi.org/10.3390/ijms24109043
APA Style
Corremans, R., Vervaet, B. A., Dams, G., D’Haese, P. C., & Verhulst, A.
(2023). Metformin and Canagliflozin Are Equally Renoprotective in Diabetic Kidney Disease but Have No Synergistic Effect. International Journal of Molecular Sciences, 24(10), 9043.
https://doi.org/10.3390/ijms24109043